Knome, Inc. was a human genome interpretation company based in Cambridge, Massachusetts, USA. Since their 2007 launch, Knome’s sole focus has been on improving lives by applying scientific insights gained from the interpretation of human genomes. Their products and services help their clients identify and classify the variants, genes, and gene sets that are likely to govern or underlie a specific disease, tumor, or drug response. Clients include academic, pharmaceutical, and medical researchers. In 2015 it was taken over by Tute Genomics.